Background illustration for clinical trials search

Small Cell Lung Cancer Clinical Trials

Browse 642 small cell lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase1, Phase2, Recruiting

Ladarixin With Sotorasib in Advanced NSCLC

for
Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Location: Garden City NY, Mineola NY, New Hyde Park NY,
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 70+

Code: NCT05815173

Phase1, Recruiting

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Boston MA, Commack NY, Baltimore MD, Ottawa, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05123482

Phase1, Phase2, Recruiting

Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

for
Non Small Cell Lung Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05254782

Recruiting

Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge

for
Non-Small Cell Lung Cancer
Location: Ottawa, Oshawa, Toronto, Brampton, Hamilton, Kitchener,
Sponsor: Mark Vincent

Sex: All

Age: 18+

Code: NCT04335292

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Multicenter Cancer Biospecimen Collection Study

for
Cancer of Head and Neck, Lung Cancer, Nonsmall Cell,
Location: San Francisco CA
Sponsor: Cofactor Genomics, Inc.

Sex: All

Age: 18+

Code: NCT04510129

Recruiting

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: The Bronx NY, Washington D.C. DC, Fairfax VA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase1, Recruiting

LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

for
Non-small Cell Lung Cancer, Oligoprogressive,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06103682

Recruiting

Talazoparib and Thoracic RT for ES-SCLC

for
Lung Cancer, Small-Cell Lung Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04170946

Phase1, Recruiting

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

for
Non-small Cell Lung Cancer
Location: Waterford CT, Guilford CT, Hamden CT, New Haven CT,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT04210492

Phase1, Phase2, Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Providence RI, Baltimore MD, Jacksonville FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase1, Phase2, Recruiting

Study of NXP900 With Lorlatinib in ALK+ Lung Cancer

for
ALK Positive, ALK Positive Non-small Cell Lung Cancer, NSCLC,
Location: Fairfax VA
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 0+

Code: NCT07784959

Phase1, Recruiting

Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

for
NSCLC, Non-small Cell Lung Cancer,
Location: Plantation FL
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07777822

Phase3, Recruiting

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

for
Small-cell Lung Cancer, Small Cell Lung Carcinoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07155200

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Farmington Hills MI, Atlanta GA, Farmington NM, Reno NV,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07541170

Phase3, Recruiting

Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

for
Non Small Cell Lung Cancer, Cardiotoxicity,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT07761910

Phase2, Recruiting

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

for
Small-cell Lung Cancer, Small Cell Lung Cancer Extensive Stage
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07545954

Phase1, Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Orange City FL, Clermont FL, Detroit MI, Atlanta GA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase1, Phase2, Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Lake Success NY, Buffalo NY, Sarasota FL,
Sponsor: InduPro, Inc.

Sex: All

Age: 18+

Code: NCT07602842

Phase1, Phase2, Recruiting

Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study

for
Stage II Lung Cancer, Lung Cancer, Non-small Cell Lung Cancer,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07412041

Recruiting